NCT02097745 - A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies | Biotech Hunter

Enrollment

341

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

methotrexate

a 10-25 mg stable dose given orally or parenterally throughout study

DRUG

rituximab [MabThera/Rituxan]

1 g given by intravenous infusion on Days 1 and 15 of each treatment course

Trial Locations (97)

4

Dublin

1070

Brussels

1200

Brussels

3004

Drammen

9000

Ghent

9038

Tromsø

10003

New York

10117

Berlin

11030

Manhasset

11787

Smithtown

12206

Albany

14618

Rochester

16635

Duncansville

19140

Philadelphia

19141

Philadelphia

19152

Philadelphia

21224

Baltimore

25123

Brescia

27834

Greenville

31059

Toulouse

32806

Orlando

33100

Udine

33334

Fort Lauderdale

33458

Jupiter

33484

Delray Beach

33486

Boca Raton

34295

Montpellier

40882

Ratingen

44143

Mayfield

45402

Dayton

46260

Indianapolis

48910

Lansing

49048

Kalamazoo

53792

Madison

55905

Rochester

56100

Pisa

60612

Chicago

60637

Chicago

63110

St Louis

63141

St Louis

71103

Shreverport

72205

Little Rock

73103

Oklahoma City

73109

Oklahoma City

74135

Tulsa

75231

Dallas

75246

Dallas

75679

Paris

76233

Bois-Guillaume

76710

Waco

77074

Houston

79124

Amarillo

83642

Meridian

83702

Boise

83814

Coeur d'Alene

84132

Salt Lake City

85208

Mesa

85253

Paradise Valley

85724

Tucson

90045

Los Angeles

90048

Los Angeles

91105

Pasadena

92270

Rancho Mirage

92835

Fullerton

93454

Santa Maria

94275

Le Kremlin-Bicêtre

97080

Würzburg

98101

Seattle

98104

Seattle

99204

Spokane

3109601

Haifa

3339419

Haifa

4941492

Petah Tikva

5262000

Ramat Gan

6423906

Tel Aviv

9112001

Jerusalem

06810

Danbury

46202-5149

Indianapolis

02215

Boston

27599-7600

Chapel Hill

45267-0563

Cincinnati

05401

Burlington

T2N 4Z6

Calgary

T6G 2S2

Edmonton

L8N 2B6

Hamilton

N6A 4V2

London

M4N 3M5

Toronto

01067

Dresden

04103

Leipzig

Unknown

Cork

1105 AZ

Amsterdam

0370

Oslo

WS11 5XY

Cannock

LS7 4SA

Leeds

E11 1NR

London

M41 5SL

Manchester

NE1 4LP

Newcastle upon Tyne